CD45 Antibody – 175Lu

Catalog: 717504                                        Clone: D9M8I                                         Isotype: Rabbit IgG
Reactivity: Human*, Monkey                                                                                  Application: MIBI-FFPE
Storage: CD45 antibody is supplied in antibody stabilizer with 0.05% sodium azide. Store at 4°C

IHC: CD45 staining of FFPE human tonsil

MIBI: CD45 staining (cyan) of FFPE human tonsil, costained with dsDNA (magenta)

IHC: CD45 antibody staining of FFPE human lymphoma

MIBI: CD45 staining (cyan) of FFPE human lymphoma, counterstained with dsDNA (magenta)

Background: CD45, also known as the leukocyte common antigen, is a type I transmembrane protein and a member of the protein tyrosine phosphatase expressed on all hematopoietic cells except mature erythrocytes, platelets and plasma cells. CD45 isoforms show cell-type and differentiation-stage specific expression, a pattern which is quite well conserved in mammals. These isoforms are often used as markers that identify and distinguish between different types of immune cells.

Validation: Each lot of conjugated antibody is quality control tested by staining tissue following the MIBI Staining Protocol optimized for the applicable tissue format with subsequent MIBIscope analysis using the appropriate positive and negative tissue field of views.

Recommended Usage:Human FFPE: 2 ug/mL dilution. For optimal results, the antibody should be titrated for each desired application.

References

  • Leupin O., Zaru R., Laroche T., Müller S., Valitutti S.Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes. Curr Biol. 2000;10(5):277-80.

* Conjugate tested on human tissue.

Contact Us

<p style="text-align: center; margin-top: 2em;">Let us know how we can help you.</p>


    Immuno-oncology/CancerNeuroscienceInfectious DiseaseImmunologyStem CellOther

    255

    Please contact me. I understand that I can choose to unsubscribe at any time by e-mailing marketing@ionpath.com.

    X
    Contact Us

    We are using cookies on our website

    Please confirm, if you accept our tracking cookies. You can also decline the tracking and continue to visit our website without any data sent to third-party services.